Coya Therapeutics, Inc. Common Stock (COYA) earnings · rev $7.9M
These earnings events as JSON? API free 100/dayCoya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
This COYA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
When the next COYA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 123.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full COYA research stays on the stock page; the tape stays on the quote page.
COYA earnings FAQ
What are COYA's latest revenue and net income?
Latest cached Coya Therapeutics, Inc. Common Stock (COYA) revenue for Dec 31, 2025 was $7.9M. Net income was -$21.2M. Statements: https://lician.com/financials/coya
What is COYA's latest diluted EPS?
Latest cached Coya Therapeutics, Inc. Common Stock (COYA) diluted EPS for Dec 31, 2025 was -$1.27.
What period does the latest COYA earnings print cover?
The latest cached Coya Therapeutics, Inc. Common Stock (COYA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did COYA revenue change from the prior cached period?
Cached Coya Therapeutics, Inc. Common Stock (COYA) revenue was up 123.6% from $3.6M (Dec 31, 2024) to $7.9M (Dec 31, 2025). Statements: https://lician.com/financials/coya
Where are COYA earnings listed?
Cached earnings facts for Coya Therapeutics, Inc. Common Stock (COYA) are listed at https://lician.com/earnings/coya. Statements: https://lician.com/financials/coya
Not investment advice.